This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Gilead Sciences Inc. rose 3.6% to $106.16 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.1% to 5,963.60 and the Dow Jones Industrial Average rising 0.3% to 42,792.07.
This was the stock's third consecutive day of gains.
Gilead Sciences Inc. closed 11.5% below its 52-week high of $119.96, which the company achieved on March 10th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 0.8% to $152.49, Pfizer Inc. rose 0.7% to $23.00, and Abbott Laboratories rose 0.56% to $135.55.
Trading volume totaled 8.5 million, compared to the 50-day average of 9.9 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 19, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.